ESTIMATING THE POTENTIAL BUDGET IMPACT OF ZELBORAF (VEMURAFENIB) FOR ADVANCED MELANOMA TREATMENT IN BRAZILIAN PRIVATE HEALTH CARE SYSTEM

被引：0
|
作者：
Tsuchiya, C. T. [1 ]
Buschinelli, C. T. [1 ]
Maximo, M. F. M. [1 ]
Tobaruella, F. S. [1 ]
Borges, L. G. [1 ]
机构：
[1] Roche Brazil, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.641
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [41] The treatment of respiratory diseases and health care budget impact within Slovakia
    Tesar, T.
    Foltan, V
    Tomek, D.
    VALUE IN HEALTH, 2006, 9 (06) : A263 - A263
  • [42] Impact of survival on health care charges during melanoma treatment
    Brixner, Diana I.
    Bellows, Brandon Kyle
    Dahal, Arati
    Stenehjem, David D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Scaccabarozzi, L.
    Asano, E.
    Guimaraes, T. B.
    VALUE IN HEALTH, 2016, 19 (03) : A244 - A244
  • [44] Budget Impact Analysis of Treatment Flow Optimization in Epilepsy Patients: Estimating Potential Impacts with Increased Referral Rate to Specialized Care
    Iwasaki, Masaki
    Saito, Takashi
    Tsubota, Akiko
    Murata, Tatsunori
    Fukuoka, Yuta
    Jin, Kazutaka
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (01): : 80 - 87
  • [45] NATIONAL GUIDELINE FOR MULTIPLE SCLEROSIS TREATMENT IN BRAZILIAN PUBLIC HEALTH: AN ANALYSIS OF TREATMENT PATTERNS AND BUDGET IMPACT
    Bueno, R. L. P.
    Pereira, M. F.
    VALUE IN HEALTH, 2008, 11 (06) : A609 - A609
  • [46] BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) PATIENTS AFTER DOCETAXEL FAILURE IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
    Asano, E.
    Vitale, V.
    VALUE IN HEALTH, 2014, 17 (07) : A622 - A622
  • [47] MELODY BRAZIL - TREATMENT PATTERNS IN BRAZILIAN HEALTH CARE SYSTEM
    Schmerling, R. A.
    Barrios, C.
    Nita, M. E.
    Stefani, S. D.
    Campos, E.
    Nunes, J.
    Biasi, L.
    Lima, L.
    Dzik, C.
    Johnston, K.
    Santinho, C. S.
    Donato, B. M. K.
    VALUE IN HEALTH, 2012, 15 (07) : A438 - A439
  • [48] TOTAL TREATMENT COSTS ANALYSIS BETWEEN SUBCUTANEOUS AND INTRAVENOUS BORTEZOMIB UNDER BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE
    Vitale, V.
    Pinto Neto, J., V
    Asano, E.
    VALUE IN HEALTH, 2014, 17 (03) : A77 - A77
  • [49] BUDGET IMPACT ANALYSIS OF FIXED-DURATION IBRUTINIB plus VENETOCLAX AS FRONTLINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
    Lima, P.
    Matsumoto, V
    Righetto, P.
    VALUE IN HEALTH, 2024, 27 (12)
  • [50] Etonogestrel-releasing subdermal contraceptive implant: Budget impact analysis based on the Brazilian private healthcare system
    da Silva Filho, Agnaldo Lopes
    Pereira Bueno, Ricardo Luis
    Ramires, Yohanna
    Cruz Lino, Lara Marina
    PLOS ONE, 2024, 19 (03):
12345